JP2018534243A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018534243A5 JP2018534243A5 JP2018511611A JP2018511611A JP2018534243A5 JP 2018534243 A5 JP2018534243 A5 JP 2018534243A5 JP 2018511611 A JP2018511611 A JP 2018511611A JP 2018511611 A JP2018511611 A JP 2018511611A JP 2018534243 A5 JP2018534243 A5 JP 2018534243A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrv
- refers
- isomer
- compound
- certain embodiments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000010992 reflux Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HIBLGLXUFLTKNR-UHFFFAOYSA-M 4-methylbenzenesulfonate N,N,1,2-tetramethylquinolin-1-ium-6-amine Chemical compound Cc1ccc(cc1)S([O-])(=O)=O.CN(C)c1ccc2[n+](C)c(C)ccc2c1 HIBLGLXUFLTKNR-UHFFFAOYSA-M 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- JGRWYZQONRFIFH-UHFFFAOYSA-N n,n,2-trimethylquinolin-6-amine Chemical compound N1=C(C)C=CC2=CC(N(C)C)=CC=C21 JGRWYZQONRFIFH-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562214613P | 2015-09-04 | 2015-09-04 | |
| US62/214,613 | 2015-09-04 | ||
| PCT/US2016/050270 WO2017041040A1 (en) | 2015-09-04 | 2016-09-02 | Androgen receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018534243A JP2018534243A (ja) | 2018-11-22 |
| JP2018534243A5 true JP2018534243A5 (enExample) | 2019-12-12 |
| JP6933644B2 JP6933644B2 (ja) | 2021-09-08 |
Family
ID=58188655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511611A Expired - Fee Related JP6933644B2 (ja) | 2015-09-04 | 2016-09-02 | アンドロゲン受容体拮抗薬 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10428048B2 (enExample) |
| EP (1) | EP3350167A4 (enExample) |
| JP (1) | JP6933644B2 (enExample) |
| CN (1) | CN108349900A (enExample) |
| WO (1) | WO2017041040A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10654809B2 (en) | 2016-06-10 | 2020-05-19 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
| US10865184B2 (en) | 2015-04-21 | 2020-12-15 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
| WO2019023651A2 (en) | 2017-07-28 | 2019-01-31 | Massachusetts Institute Of Technology | MODULATORS OF THE SMALL MOLECULE ANDROGEN RECEPTOR |
| AU2018316248A1 (en) * | 2017-08-09 | 2020-01-30 | Nangenex Nanotechnology Incorporated | Pharmaceutical composition comprising Abiraterone acetate and Darulotamide |
| CN115701991A (zh) * | 2020-04-02 | 2023-02-14 | 田纳西大学研究基金会 | 吡唑基丙酰胺化合物及其用于治疗前列腺癌的用途 |
| CN114685601B (zh) | 2020-12-30 | 2024-10-18 | 财团法人工业技术研究院 | 雄性激素受体结合分子及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH509382A (it) | 1967-06-23 | 1971-06-30 | Crc Ricerca Chim | Metodo per l'ottenimento dei colori pirolchinolici e dei loro sali derivati |
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| EP0495421B1 (en) | 1991-01-15 | 1996-08-21 | Alcon Laboratories, Inc. | Use of carrageenans in topical ophthalmic compositions |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| EP1841428A1 (en) * | 2005-01-18 | 2007-10-10 | Immusol Incorporated | Novel quinolinium salts and derivatives |
| CN101106992A (zh) * | 2005-01-18 | 2008-01-16 | 伊姆索公司 | 新颖的喹啉鎓盐和衍生物 |
| WO2008128100A1 (en) | 2007-04-13 | 2008-10-23 | The Regents Of The University Of California | Small-molecule inhibitors of the androgen receptor |
| US8354538B2 (en) | 2008-04-24 | 2013-01-15 | The Regents Of The University Of California | Small-molecule inhibitors of the androgen receptor |
| KR102193461B1 (ko) * | 2014-04-24 | 2020-12-21 | 동아에스티 주식회사 | 퀴놀린계 화합물 및 이를 포함하는 선택적 안드로겐 수용체 효능제 |
-
2016
- 2016-09-02 JP JP2018511611A patent/JP6933644B2/ja not_active Expired - Fee Related
- 2016-09-02 EP EP16843143.5A patent/EP3350167A4/en not_active Withdrawn
- 2016-09-02 CN CN201680064061.1A patent/CN108349900A/zh active Pending
- 2016-09-02 WO PCT/US2016/050270 patent/WO2017041040A1/en not_active Ceased
- 2016-09-02 US US15/757,238 patent/US10428048B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018534243A5 (enExample) | ||
| CL2008001898A1 (es) | Compuestos derivados de pirazinona, inhibidores de p38; proceso de preparacion de estos; composicion farmaceutica que los comprende; combinacion farmaceutica que los comprende; uso para tratar enferemedades pulmonares obstructivas cronicas y asma. | |
| JP2013063963A5 (ja) | 複素環化合物 | |
| JP2015532645A5 (enExample) | ||
| DK2158185T3 (da) | Fremgangsmåde til fremstilling af difluormethylsubstituerede pyrazolforbindelser | |
| JP2016505614A5 (enExample) | ||
| JP2016531126A5 (enExample) | ||
| JP2014043437A5 (ja) | 有機化合物 | |
| MX377644B (es) | 6.7.beta-epóxidos esteroideos como intermedios químicos. | |
| MX2018014164A (es) | Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico. | |
| WO2021111462A1 (en) | An improved process for the preparation of osimertinib mesylate | |
| RU2016148821A (ru) | Способ радиомечения | |
| JP2020502116A5 (enExample) | ||
| JP2019523279A5 (enExample) | ||
| JP2013531021A (ja) | フェブキソスタットの結晶形ｉｉを調製するための方法 | |
| CN102850282A (zh) | 3－烷氧基取代－2－吡嗪甲酰氨类化合物及其用途 | |
| CN103664931A (zh) | 一种含苯并噻唑环和咪唑环希夫碱化合物及其制备方法 | |
| JP2017511361A5 (enExample) | ||
| WO2016110798A1 (en) | An improved process for the preparation of lurasidone and its intermediate | |
| CN111247160A (zh) | 一种胆酸类化合物的制备方法 | |
| CN106008506B (zh) | 取代嘌呤类衍生物及其制备方法与应用 | |
| Sheibani | Regioselective combination of 1, 3-dinucleophiles such as 2-mercaptobenzimidazole, 5-mercapto-3-phenyltriazole and potassium thiocyanate with 2, 2-dicyanooxiranes | |
| CN104059020A (zh) | 1-芳基-5-羟基吡唑的制备方法 | |
| JP2017095442A5 (enExample) | ||
| CN103275021A (zh) | N-二氯乙酰基-6,7-二氯-1,2,3,4-四氢喹喔啉及其制备方法 |